UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053380
Receipt number R000060920
Scientific Title Preventive effects for wound infection by the irrigation with povidone-iodine saline in patients undergoing gastrointestinal surgery: A randomized controlled study
Date of disclosure of the study information 2024/01/20
Last modified on 2024/01/17 22:03:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preventive effects for wound infection by the irrigation with povidone-iodine saline in patients undergoing gastrointestinal surgery: A randomized controlled study

Acronym

Preventive effects for wound infection by the irrigation with povidone-iodine saline

Scientific Title

Preventive effects for wound infection by the irrigation with povidone-iodine saline in patients undergoing gastrointestinal surgery: A randomized controlled study

Scientific Title:Acronym

Preventive effects for wound infection by the irrigation with povidone-iodine saline

Region

Japan


Condition

Condition

Patients undergoing open gastrointestinal surgery.

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To test preventive effects for wound infection by povidone-iodine saline irrigation in patients undergoing open gastrointestinal surgery (control; irrigation by saline) through a randomized controlled study.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase II


Assessment

Primary outcomes

The incidence rate of postoperative wound infection.

Key secondary outcomes

1. Detection of remnant bacteria in the wound after wound irrigation.
2. The association between the bacteria detected in the wound and those detected in preoperatively collected feces.
3. In case of wound infection, investigate the association between the bacteria detected in the wound infection, those detected in preoperatively collected feces, and those detected in the blood collected before surgery.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -but assessor(s) are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Wound irrigation with povidone-iodine saline.

Interventions/Control_2

Wound irrigation by saline.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients undergoing open gastrointestinal surgery.

Key exclusion criteria

Patients who are allergic to iodine.
Patients who disagreed to participate in the study.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Eiji
Middle name
Last name Sasaki

Organization

Meijo Hospital

Division name

Department of Surgery

Zip code

460-0001

Address

1-3-1 Sannomaru, Naka-ku, Nagoya, Aichi, Japan

TEL

052-201-5311

Email

e-sasaki@meijohosp.com


Public contact

Name of contact person

1st name Yukihiro
Middle name
Last name Yokoyama

Organization

Nagoya University Graduate School of Medicine

Division name

Division of Surgical Oncology, Department of Surgery

Zip code

4668550

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

0527442222

Homepage URL


Email

yyoko@med.nagoya-u.ac.jp


Sponsor or person

Institute

Meijo Hospital

Institute

Department

Personal name

Eiji Sasaki


Funding Source

Organization

Meijo Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Meijo Hospital Ethics Committee

Address

1-3-1 Sannomaru, Naka-ku, Nagoya, Aichi, Japan

Tel

0522015311

Email

shinryojoho@meijohosp.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 08 Month 22 Day

Date of IRB

2023 Year 08 Month 22 Day

Anticipated trial start date

2024 Year 01 Month 20 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 01 Month 17 Day

Last modified on

2024 Year 01 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060920


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name